

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.08620830 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.89579655 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.89579655 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.84952910 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.84952910 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.31516810 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.24632205 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.80059216 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.80059216 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.80059216 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 5.77366600 |
| 12 | cysteine metabolic process (GO:0006534) | 5.74592571 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.61749295 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.60456623 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.46840202 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.43415938 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 5.33133754 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.32919621 |
| 19 | glycine metabolic process (GO:0006544) | 5.30208798 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.14525888 |
| 21 | homocysteine metabolic process (GO:0050667) | 5.03754804 |
| 22 | serine family amino acid metabolic process (GO:0009069) | 4.92549508 |
| 23 | aromatic amino acid family metabolic process (GO:0009072) | 4.88388033 |
| 24 | serine family amino acid biosynthetic process (GO:0009070) | 4.82513270 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.81374305 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.76974535 |
| 27 | lysine metabolic process (GO:0006553) | 4.75315089 |
| 28 | lysine catabolic process (GO:0006554) | 4.75315089 |
| 29 | urea cycle (GO:0000050) | 4.74880009 |
| 30 | urea metabolic process (GO:0019627) | 4.74880009 |
| 31 | drug metabolic process (GO:0017144) | 4.72920550 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.66098883 |
| 33 | alpha-amino acid catabolic process (GO:1901606) | 4.63167817 |
| 34 | ethanol metabolic process (GO:0006067) | 4.52496982 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.50933524 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.49221168 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.47163101 |
| 38 | oxidative demethylation (GO:0070989) | 4.47093976 |
| 39 | bile acid metabolic process (GO:0008206) | 4.44828211 |
| 40 | complement activation, alternative pathway (GO:0006957) | 4.44055984 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.41396967 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.40727836 |
| 43 | protein carboxylation (GO:0018214) | 4.40727836 |
| 44 | regulation of complement activation (GO:0030449) | 4.38516669 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 4.37225358 |
| 46 | regulation of fibrinolysis (GO:0051917) | 4.35483357 |
| 47 | cellular modified amino acid catabolic process (GO:0042219) | 4.21307094 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.09890564 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.09890564 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.08967812 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.08616441 |
| 52 | amine catabolic process (GO:0009310) | 4.04925088 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.04925088 |
| 54 | coenzyme catabolic process (GO:0009109) | 4.04805427 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.04688499 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.03434971 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.03434971 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 4.00517442 |
| 59 | complement activation, classical pathway (GO:0006958) | 3.99981398 |
| 60 | folic acid metabolic process (GO:0046655) | 3.97365912 |
| 61 | urate metabolic process (GO:0046415) | 3.97256402 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.95684011 |
| 63 | protein activation cascade (GO:0072376) | 3.94737044 |
| 64 | glutamate metabolic process (GO:0006536) | 3.93395344 |
| 65 | negative regulation of protein activation cascade (GO:2000258) | 3.89356735 |
| 66 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87816823 |
| 67 | L-serine metabolic process (GO:0006563) | 3.85384870 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.85135112 |
| 69 | complement activation (GO:0006956) | 3.84875531 |
| 70 | carboxylic acid catabolic process (GO:0046395) | 3.81115207 |
| 71 | organic acid catabolic process (GO:0016054) | 3.81115207 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.80689222 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80366726 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 3.80366726 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.80366726 |
| 76 | fibrinolysis (GO:0042730) | 3.79091522 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.78893316 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.78893316 |
| 79 | branched-chain amino acid catabolic process (GO:0009083) | 3.76114010 |
| 80 | valine metabolic process (GO:0006573) | 3.75412653 |
| 81 | bile acid and bile salt transport (GO:0015721) | 3.74792464 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.74480670 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.72736667 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71510519 |
| 85 | fructose metabolic process (GO:0006000) | 3.67605947 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.67463741 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66866434 |
| 88 | drug catabolic process (GO:0042737) | 3.65673828 |
| 89 | heme transport (GO:0015886) | 3.64775487 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.63193025 |
| 91 | phenylpropanoid metabolic process (GO:0009698) | 3.60932847 |
| 92 | flavonoid metabolic process (GO:0009812) | 3.60421301 |
| 93 | ethanol oxidation (GO:0006069) | 3.59540635 |
| 94 | alkaloid metabolic process (GO:0009820) | 3.58649926 |
| 95 | regulation of plasminogen activation (GO:0010755) | 3.57803610 |
| 96 | phospholipid efflux (GO:0033700) | 3.55123207 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 3.54285084 |
| 98 | arginine metabolic process (GO:0006525) | 3.52132586 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.50756600 |
| 100 | regulation of humoral immune response (GO:0002920) | 3.49530975 |
| 101 | carnitine metabolic process (GO:0009437) | 3.48243534 |
| 102 | cellular glucuronidation (GO:0052695) | 3.48081095 |
| 103 | drug transmembrane transport (GO:0006855) | 3.47482152 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.46703424 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.45976106 |
| 106 | negative regulation of complement activation (GO:0045916) | 3.45868638 |
| 107 | branched-chain amino acid metabolic process (GO:0009081) | 3.45251211 |
| 108 | fatty acid beta-oxidation (GO:0006635) | 3.45109496 |
| 109 | acute-phase response (GO:0006953) | 3.44292751 |
| 110 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.43986531 |
| 111 | sulfur amino acid metabolic process (GO:0000096) | 3.42211634 |
| 112 | fatty acid oxidation (GO:0019395) | 3.39784431 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.39594382 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38188387 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38188387 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.38029944 |
| 117 | biotin metabolic process (GO:0006768) | 3.36925444 |
| 118 | cholesterol efflux (GO:0033344) | 3.33644633 |
| 119 | sterol homeostasis (GO:0055092) | 3.33536084 |
| 120 | lipid oxidation (GO:0034440) | 3.33165844 |
| 121 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.33121915 |
| 122 | pantothenate metabolic process (GO:0015939) | 3.32837019 |
| 123 | monocarboxylic acid catabolic process (GO:0072329) | 3.29561271 |
| 124 | fatty acid catabolic process (GO:0009062) | 3.29394215 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.27590569 |
| 126 | negative regulation of hemostasis (GO:1900047) | 3.20448731 |
| 127 | negative regulation of blood coagulation (GO:0030195) | 3.20448731 |
| 128 | plasma lipoprotein particle organization (GO:0071827) | 3.05481002 |
| 129 | ketone body metabolic process (GO:1902224) | 3.02150172 |
| 130 | negative regulation of humoral immune response (GO:0002921) | 2.95671869 |
| 131 | fatty acid transmembrane transport (GO:1902001) | 2.95599813 |
| 132 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.92587974 |
| 133 | opsonization (GO:0008228) | 2.91882911 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.91306363 |
| 135 | quaternary ammonium group transport (GO:0015697) | 2.90483730 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 2.89727401 |
| 137 | regulation of triglyceride metabolic process (GO:0090207) | 2.89417311 |
| 138 | xenobiotic metabolic process (GO:0006805) | 2.88048413 |
| 139 | negative regulation of coagulation (GO:0050819) | 2.85876584 |
| 140 | lipoprotein metabolic process (GO:0042157) | 2.85787088 |
| 141 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.85322069 |
| 142 | cytolysis (GO:0019835) | 2.79591160 |
| 143 | regulation of apoptotic cell clearance (GO:2000425) | 2.77770314 |
| 144 | negative regulation of wound healing (GO:0061045) | 2.76835110 |
| 145 | primary alcohol metabolic process (GO:0034308) | 2.76732290 |
| 146 | primary alcohol catabolic process (GO:0034310) | 2.75684064 |
| 147 | response to mercury ion (GO:0046689) | 2.74654661 |
| 148 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.71301069 |
| 149 | phospholipid homeostasis (GO:0055091) | 2.69854857 |
| 150 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.69809568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.42992342 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.64637619 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.92065476 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.13261292 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.93920060 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.65003954 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.38701838 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.26449376 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51961142 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.02820484 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.60199325 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17809044 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08536417 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.07930419 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05245211 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02693598 |
| 17 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.82128445 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80457618 |
| 19 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.73660797 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69242295 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67291118 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67055616 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.63589230 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.63273624 |
| 25 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62881413 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58906741 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52873962 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49658966 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47866970 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46805614 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46204626 |
| 32 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44089066 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42494492 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41455789 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39870512 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.38440329 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38193787 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38023650 |
| 39 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.33857545 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.33199634 |
| 41 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32237526 |
| 42 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31900236 |
| 43 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26930892 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25998667 |
| 45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25511284 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24283043 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22535023 |
| 48 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21113683 |
| 49 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21008233 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20672311 |
| 51 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.17957375 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17377506 |
| 53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.15988665 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14992236 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14267836 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14034888 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13983557 |
| 58 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.13377216 |
| 59 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.13377216 |
| 60 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.13377216 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13202331 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.11387410 |
| 63 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10419804 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09908999 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07930045 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07659985 |
| 67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07187040 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07060201 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06864471 |
| 70 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06118328 |
| 71 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05395780 |
| 72 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04293603 |
| 73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04182015 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03281787 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01307115 |
| 76 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99877589 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99761185 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99644673 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99282772 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99124154 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98207911 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98169266 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97920675 |
| 84 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.97758911 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96761391 |
| 86 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96585162 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.95853707 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95807430 |
| 89 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95529799 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95529630 |
| 91 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94606605 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93522550 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 0.92807929 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92699033 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92576417 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91118772 |
| 97 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.90999882 |
| 98 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90587510 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90388024 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89901743 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89682308 |
| 102 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89288722 |
| 103 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89199612 |
| 104 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88888641 |
| 105 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88592056 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88396658 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88126778 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87548486 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86716577 |
| 110 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86257511 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86218755 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85724925 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85638594 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85601386 |
| 115 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85388675 |
| 116 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84912912 |
| 117 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.84823689 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84785227 |
| 119 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84666518 |
| 120 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84288497 |
| 121 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84084245 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83935246 |
| 123 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83747701 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83604914 |
| 125 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82921179 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82798569 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82738677 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82656899 |
| 129 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.82551554 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82431534 |
| 131 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82334085 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82272698 |
| 133 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82163553 |
| 134 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81345831 |
| 135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80786325 |
| 136 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80761753 |
| 137 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80730474 |
| 138 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80114393 |
| 139 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79536650 |
| 140 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78232701 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78161682 |
| 142 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77968396 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77777275 |
| 144 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77699905 |
| 145 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.77580764 |
| 146 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.77453942 |
| 147 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77035848 |
| 148 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77035848 |
| 149 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76597359 |
| 150 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.76155012 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75558065 |
| 152 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.75484208 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75145903 |
| 154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74756844 |
| 155 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74654997 |
| 156 | P300_27268052_Chip-Seq_Bcells_Human | 0.74550758 |
| 157 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74529324 |
| 158 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.74163301 |
| 159 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73680208 |
| 160 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.73557680 |
| 161 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.73215259 |
| 162 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72272935 |
| 163 | ATF3_27146783_Chip-Seq_COLON_Human | 0.71704067 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70958897 |
| 165 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.70799578 |
| 166 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67947372 |
| 167 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.66963295 |
| 168 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.66868885 |
| 169 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.65417473 |
| 170 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.65093901 |
| 171 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.64707229 |
| 172 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63980819 |
| 173 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62534217 |
| 174 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.61791670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.40554100 |
| 2 | MP0005360_urolithiasis | 6.64084853 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.86939773 |
| 4 | MP0005365_abnormal_bile_salt | 5.84146839 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.65919664 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.44762511 |
| 7 | MP0009840_abnormal_foam_cell | 3.77729606 |
| 8 | MP0003252_abnormal_bile_duct | 3.33283243 |
| 9 | MP0005332_abnormal_amino_acid | 3.22418329 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.19747933 |
| 11 | MP0003195_calcinosis | 3.17937698 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.81415536 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.78090545 |
| 14 | MP0005083_abnormal_biliary_tract | 2.76876556 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.05674199 |
| 16 | MP0000609_abnormal_liver_physiology | 2.02333680 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.00367623 |
| 18 | MP0005319_abnormal_enzyme/_coenzyme | 1.88878389 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.82791118 |
| 20 | MP0001764_abnormal_homeostasis | 1.76602926 |
| 21 | MP0003879_abnormal_hair_cell | 1.73065622 |
| 22 | MP0005451_abnormal_body_composition | 1.67813760 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.62563344 |
| 24 | MP0003868_abnormal_feces_composition | 1.60379692 |
| 25 | MP0003186_abnormal_redox_activity | 1.59320833 |
| 26 | MP0003646_muscle_fatigue | 1.55355886 |
| 27 | MP0003718_maternal_effect | 1.39822647 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.37045557 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.32033887 |
| 30 | MP0005670_abnormal_white_adipose | 1.29086857 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27716352 |
| 32 | MP0000751_myopathy | 1.24078391 |
| 33 | MP0003045_fibrosis | 1.21772089 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.21141624 |
| 35 | MP0001756_abnormal_urination | 1.20383976 |
| 36 | MP0002254_reproductive_system_inflammat | 1.17324701 |
| 37 | MP0000598_abnormal_liver_morphology | 1.15058058 |
| 38 | MP0003011_delayed_dark_adaptation | 1.13986318 |
| 39 | MP0002933_joint_inflammation | 1.13395289 |
| 40 | MP0003878_abnormal_ear_physiology | 1.11433350 |
| 41 | MP0005377_hearing/vestibular/ear_phenot | 1.11433350 |
| 42 | MP0005409_darkened_coat_color | 1.11371505 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.09982285 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.08853175 |
| 45 | MP0009697_abnormal_copulation | 1.06305495 |
| 46 | MP0001661_extended_life_span | 1.06275548 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.05836392 |
| 48 | MP0005647_abnormal_sex_gland | 1.04153461 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.02362139 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.01830251 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.01365990 |
| 52 | MP0006138_congestive_heart_failure | 1.01044069 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 0.96668924 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.95544480 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 0.95264768 |
| 56 | MP0008872_abnormal_physiological_respon | 0.95142410 |
| 57 | MP0005395_other_phenotype | 0.94786798 |
| 58 | MP0001501_abnormal_sleep_pattern | 0.94539883 |
| 59 | MP0002249_abnormal_larynx_morphology | 0.90774610 |
| 60 | MP0001958_emphysema | 0.90426892 |
| 61 | MP0001873_stomach_inflammation | 0.89401061 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.89331979 |
| 63 | MP0004084_abnormal_cardiac_muscle | 0.86440784 |
| 64 | MP0000249_abnormal_blood_vessel | 0.86295822 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.86160288 |
| 66 | MP0001502_abnormal_circadian_rhythm | 0.82320367 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.80739903 |
| 68 | MP0004043_abnormal_pH_regulation | 0.79884862 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.78737739 |
| 70 | MP0005266_abnormal_metabolism | 0.78680191 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.78305027 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.77603419 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.76979127 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.74428228 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.74294577 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.74111995 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.73538439 |
| 78 | MP0002971_abnormal_brown_adipose | 0.73299152 |
| 79 | MP0009763_increased_sensitivity_to | 0.73052553 |
| 80 | MP0002796_impaired_skin_barrier | 0.73017747 |
| 81 | MP0000685_abnormal_immune_system | 0.71537970 |
| 82 | MP0008775_abnormal_heart_ventricle | 0.71456392 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.71163506 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.70304316 |
| 85 | MP0009053_abnormal_anal_canal | 0.69288634 |
| 86 | MP0000604_amyloidosis | 0.67444649 |
| 87 | MP0001664_abnormal_digestion | 0.66500500 |
| 88 | MP0000566_synostosis | 0.65940429 |
| 89 | MP0005408_hypopigmentation | 0.65406621 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.65043646 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.64357793 |
| 92 | MP0008260_abnormal_autophagy | 0.62320761 |
| 93 | MP0009764_decreased_sensitivity_to | 0.61497318 |
| 94 | MP0008469_abnormal_protein_level | 0.61214618 |
| 95 | MP0005334_abnormal_fat_pad | 0.60005738 |
| 96 | MP0009672_abnormal_birth_weight | 0.59909718 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.59547801 |
| 98 | MP0004957_abnormal_blastocyst_morpholog | 0.59400100 |
| 99 | MP0002269_muscular_atrophy | 0.58899332 |
| 100 | MP0003329_amyloid_beta_deposits | 0.57396627 |
| 101 | MP0005164_abnormal_response_to | 0.57168713 |
| 102 | MP0005166_decreased_susceptibility_to | 0.57138291 |
| 103 | MP0004130_abnormal_muscle_cell | 0.56384485 |
| 104 | MP0003690_abnormal_glial_cell | 0.55682245 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.55196397 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.54743848 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.54731345 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.54669780 |
| 109 | MP0004510_myositis | 0.53701361 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.53221872 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.52438201 |
| 112 | MP0004883_abnormal_blood_vessel | 0.50776876 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.48826898 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.48457662 |
| 115 | MP0002168_other_aberrant_phenotype | 0.47990769 |
| 116 | MP0003953_abnormal_hormone_level | 0.47263942 |
| 117 | MP0005535_abnormal_body_temperature | 0.46774205 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.44613400 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.43862842 |
| 120 | MP0005330_cardiomyopathy | 0.43408456 |
| 121 | MP0005448_abnormal_energy_balance | 0.41888080 |
| 122 | MP0000579_abnormal_nail_morphology | 0.41177132 |
| 123 | MP0002970_abnormal_white_adipose | 0.40547491 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.39841309 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.39510798 |
| 126 | MP0002132_abnormal_respiratory_system | 0.39097180 |
| 127 | MP0000358_abnormal_cell_content/ | 0.38556144 |
| 128 | MP0002060_abnormal_skin_morphology | 0.37629748 |
| 129 | MP0001542_abnormal_bone_strength | 0.36401752 |
| 130 | MP0009115_abnormal_fat_cell | 0.35293328 |
| 131 | MP0004381_abnormal_hair_follicle | 0.34710197 |
| 132 | MP0001881_abnormal_mammary_gland | 0.34344348 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.33820470 |
| 134 | MP0003699_abnormal_female_reproductive | 0.33647688 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.33007823 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.32541424 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.32367588 |
| 138 | MP0003890_abnormal_embryonic-extraembry | 0.31969648 |
| 139 | MP0001730_embryonic_growth_arrest | 0.31866530 |
| 140 | MP0001672_abnormal_embryogenesis/_devel | 0.31305872 |
| 141 | MP0005380_embryogenesis_phenotype | 0.31305872 |
| 142 | MP0000647_abnormal_sebaceous_gland | 0.31222732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.68693945 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.26880583 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.96432825 |
| 4 | Xanthomatosis (HP:0000991) | 5.81483125 |
| 5 | Hyperglycinemia (HP:0002154) | 5.65714937 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.57961154 |
| 7 | Hyperglycinuria (HP:0003108) | 5.54518990 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.52179404 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.15526063 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.11056541 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 5.11056541 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.08171187 |
| 13 | Hyperammonemia (HP:0001987) | 4.76078526 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.43404422 |
| 15 | Glomerulonephritis (HP:0000099) | 4.35890121 |
| 16 | Ketosis (HP:0001946) | 4.35678743 |
| 17 | Complement deficiency (HP:0004431) | 4.29433572 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24771941 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.20924834 |
| 20 | Gout (HP:0001997) | 4.15860823 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.10014052 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98032134 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.97049102 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.93831393 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.92446081 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79592270 |
| 27 | Abnormality of serum amino acid levels (HP:0003112) | 3.78959166 |
| 28 | Fat malabsorption (HP:0002630) | 3.66511388 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.65419031 |
| 30 | Nephritis (HP:0000123) | 3.63248408 |
| 31 | Epidermoid cyst (HP:0200040) | 3.59133052 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53247494 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.42405530 |
| 34 | Joint hemorrhage (HP:0005261) | 3.39041426 |
| 35 | Ketoacidosis (HP:0001993) | 3.38150059 |
| 36 | Hemorrhage of the eye (HP:0011885) | 3.32559536 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.32065839 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30400846 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 3.29861814 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.29861814 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26207532 |
| 42 | Lethargy (HP:0001254) | 3.23047428 |
| 43 | Abnormality of complement system (HP:0005339) | 3.08992198 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.06601782 |
| 45 | Decreased circulating renin level (HP:0003351) | 3.03907262 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.03357708 |
| 47 | Steatorrhea (HP:0002570) | 2.87244110 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82665401 |
| 49 | Metabolic acidosis (HP:0001942) | 2.81299368 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.79097027 |
| 51 | Proximal tubulopathy (HP:0000114) | 2.73429479 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.70775856 |
| 53 | Hyperuricemia (HP:0002149) | 2.69349706 |
| 54 | Increased purine levels (HP:0004368) | 2.69349706 |
| 55 | Cerebral palsy (HP:0100021) | 2.69187250 |
| 56 | Myocardial infarction (HP:0001658) | 2.68004411 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.61947600 |
| 58 | Irritability (HP:0000737) | 2.61652113 |
| 59 | Malnutrition (HP:0004395) | 2.61051194 |
| 60 | Cerebral edema (HP:0002181) | 2.58019755 |
| 61 | Fair hair (HP:0002286) | 2.55997530 |
| 62 | Hyperglycemia (HP:0003074) | 2.54654282 |
| 63 | Facial shape deformation (HP:0011334) | 2.47601795 |
| 64 | Potter facies (HP:0002009) | 2.47601795 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.45592875 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.44915537 |
| 67 | Vascular calcification (HP:0004934) | 2.42506883 |
| 68 | Spontaneous abortion (HP:0005268) | 2.41773947 |
| 69 | Skin nodule (HP:0200036) | 2.41766374 |
| 70 | Vomiting (HP:0002013) | 2.37746796 |
| 71 | Abnormal cartilage morphology (HP:0002763) | 2.36735968 |
| 72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32571769 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.30467100 |
| 74 | Megaloblastic anemia (HP:0001889) | 2.29687768 |
| 75 | Late onset (HP:0003584) | 2.29238199 |
| 76 | Spastic diplegia (HP:0001264) | 2.27873314 |
| 77 | Mitral stenosis (HP:0001718) | 2.23339399 |
| 78 | Heart block (HP:0012722) | 2.22876738 |
| 79 | Generalized hypopigmentation of hair (HP:0011358) | 2.21970454 |
| 80 | Bronchomalacia (HP:0002780) | 2.19119804 |
| 81 | Exercise-induced myalgia (HP:0003738) | 2.18374625 |
| 82 | Nausea (HP:0002018) | 2.17219766 |
| 83 | Brushfield spots (HP:0001088) | 2.15694353 |
| 84 | Pancreatitis (HP:0001733) | 2.13912999 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.11467860 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.10957451 |
| 87 | Glycosuria (HP:0003076) | 2.10957451 |
| 88 | Atrioventricular block (HP:0001678) | 2.10571983 |
| 89 | Neonatal onset (HP:0003623) | 2.09922597 |
| 90 | Abnormal atrioventricular conduction (HP:0005150) | 2.08985905 |
| 91 | Esophageal varix (HP:0002040) | 2.07795269 |
| 92 | Obstructive sleep apnea (HP:0002870) | 2.05273454 |
| 93 | Pigmentary retinal degeneration (HP:0001146) | 2.05004264 |
| 94 | Opisthotonus (HP:0002179) | 2.02752609 |
| 95 | Abnormality of renin-angiotensin system (HP:0000847) | 2.02098102 |
| 96 | Rickets (HP:0002748) | 2.00514418 |
| 97 | Hyperventilation (HP:0002883) | 1.99228242 |
| 98 | Gingival bleeding (HP:0000225) | 1.98183461 |
| 99 | Joint swelling (HP:0001386) | 1.96644396 |
| 100 | Enlarged kidneys (HP:0000105) | 1.95889381 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 1.94111789 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 1.93377657 |
| 103 | Multiple enchondromatosis (HP:0005701) | 1.92476081 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92339994 |
| 105 | Alkalosis (HP:0001948) | 1.92081885 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91616913 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91616913 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91616913 |
| 109 | Neonatal hypoglycemia (HP:0001998) | 1.91527275 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.90198289 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90198289 |
| 112 | Lymphangioma (HP:0100764) | 1.89563841 |
| 113 | Spastic paraparesis (HP:0002313) | 1.88933955 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.88462710 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.88462710 |
| 116 | Hyperkalemia (HP:0002153) | 1.87921671 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.85441124 |
| 118 | Prolonged QT interval (HP:0001657) | 1.83381217 |
| 119 | Arthropathy (HP:0003040) | 1.82337729 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78262308 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 1.78033436 |
| 122 | Methylmalonic aciduria (HP:0012120) | 1.76608537 |
| 123 | Renal cortical cysts (HP:0000803) | 1.75326226 |
| 124 | Abnormal gallbladder morphology (HP:0012437) | 1.74984775 |
| 125 | Pulmonary embolism (HP:0002204) | 1.73753177 |
| 126 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72958337 |
| 127 | Widely patent fontanelles and sutures (HP:0004492) | 1.72674649 |
| 128 | Cholelithiasis (HP:0001081) | 1.72045711 |
| 129 | Menorrhagia (HP:0000132) | 1.71250333 |
| 130 | Symptomatic seizures (HP:0011145) | 1.70348638 |
| 131 | Back pain (HP:0003418) | 1.70078107 |
| 132 | Purpura (HP:0000979) | 1.69894626 |
| 133 | Syncope (HP:0001279) | 1.69052334 |
| 134 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67891237 |
| 135 | Confusion (HP:0001289) | 1.67650815 |
| 136 | Acute hepatic failure (HP:0006554) | 1.67556775 |
| 137 | J-shaped sella turcica (HP:0002680) | 1.67318456 |
| 138 | Stroke (HP:0001297) | 1.66552511 |
| 139 | CNS demyelination (HP:0007305) | 1.66137491 |
| 140 | Ileus (HP:0002595) | 1.65848779 |
| 141 | Rectal prolapse (HP:0002035) | 1.65454948 |
| 142 | Aortic aneurysm (HP:0004942) | 1.64520088 |
| 143 | Bundle branch block (HP:0011710) | 1.64210450 |
| 144 | Abnormality of potassium homeostasis (HP:0011042) | 1.63484854 |
| 145 | Hypertriglyceridemia (HP:0002155) | 1.61453598 |
| 146 | Abnormal urine output (HP:0012590) | 1.60881266 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.60609707 |
| 148 | Amelogenesis imperfecta (HP:0000705) | 1.58824860 |
| 149 | Abnormality of renal excretion (HP:0011036) | 1.55805087 |
| 150 | Blue irides (HP:0000635) | 1.55802233 |
| 151 | Hypokalemia (HP:0002900) | 1.55494811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.01389380 |
| 2 | EPHA2 | 4.26573506 |
| 3 | ERN1 | 3.21586398 |
| 4 | FGFR4 | 3.06904216 |
| 5 | AKT3 | 2.82481384 |
| 6 | SIK1 | 2.62145496 |
| 7 | BUB1 | 2.47724373 |
| 8 | STK38L | 2.40270428 |
| 9 | WEE1 | 2.35228715 |
| 10 | MYLK | 2.21951858 |
| 11 | RIPK1 | 2.06180101 |
| 12 | NEK1 | 2.05755029 |
| 13 | MAP3K7 | 1.94101252 |
| 14 | MST1R | 1.90324397 |
| 15 | PDK3 | 1.88112156 |
| 16 | PDK4 | 1.88112156 |
| 17 | PINK1 | 1.84429720 |
| 18 | TNK2 | 1.84315703 |
| 19 | INSRR | 1.71059757 |
| 20 | IRAK3 | 1.66516353 |
| 21 | NME2 | 1.66389589 |
| 22 | DAPK2 | 1.61425077 |
| 23 | EEF2K | 1.59231245 |
| 24 | ERBB4 | 1.58410123 |
| 25 | STK16 | 1.58378174 |
| 26 | TRIB3 | 1.57675575 |
| 27 | OBSCN | 1.56348997 |
| 28 | TTK | 1.55386388 |
| 29 | LATS1 | 1.54146409 |
| 30 | CDC42BPA | 1.53389540 |
| 31 | MAPK11 | 1.44237066 |
| 32 | PDK2 | 1.43538393 |
| 33 | PIK3CA | 1.40970762 |
| 34 | MAP3K3 | 1.39832877 |
| 35 | TRPM7 | 1.35048350 |
| 36 | MAP3K13 | 1.33140466 |
| 37 | FGFR3 | 1.28169447 |
| 38 | MAPK15 | 1.27291076 |
| 39 | EIF2AK1 | 1.24229859 |
| 40 | TTN | 1.23700131 |
| 41 | ABL2 | 1.19601211 |
| 42 | WNK3 | 1.17435779 |
| 43 | MAP4K1 | 1.13418379 |
| 44 | EPHB1 | 1.11103525 |
| 45 | MARK2 | 1.09595819 |
| 46 | NLK | 1.09085717 |
| 47 | MAP2K2 | 1.08028715 |
| 48 | PHKG1 | 1.07349495 |
| 49 | PHKG2 | 1.07349495 |
| 50 | TAOK2 | 1.07113495 |
| 51 | TAOK3 | 1.06321784 |
| 52 | LATS2 | 1.05999383 |
| 53 | EIF2AK3 | 1.04863428 |
| 54 | MUSK | 1.04253700 |
| 55 | MET | 1.02943677 |
| 56 | ZAK | 1.00583334 |
| 57 | PDPK1 | 0.99958594 |
| 58 | PRKCI | 0.99539763 |
| 59 | MAP3K11 | 0.96041067 |
| 60 | NEK2 | 0.94698090 |
| 61 | FLT3 | 0.94477130 |
| 62 | MAP3K6 | 0.94411865 |
| 63 | PRKD2 | 0.93878799 |
| 64 | ZAP70 | 0.93876150 |
| 65 | DMPK | 0.93866165 |
| 66 | HIPK2 | 0.91093816 |
| 67 | PIK3CG | 0.89994387 |
| 68 | NTRK3 | 0.89871574 |
| 69 | BLK | 0.89694575 |
| 70 | DYRK3 | 0.89305080 |
| 71 | PLK4 | 0.87683439 |
| 72 | BRAF | 0.85829894 |
| 73 | PKN2 | 0.84848397 |
| 74 | ADRBK2 | 0.84661958 |
| 75 | JAK1 | 0.84498892 |
| 76 | PAK3 | 0.81850661 |
| 77 | CDK4 | 0.80661207 |
| 78 | PDK1 | 0.80399697 |
| 79 | TBK1 | 0.79195131 |
| 80 | BRSK2 | 0.77251313 |
| 81 | CAMK2G | 0.76378547 |
| 82 | MAP2K3 | 0.76079555 |
| 83 | ACVR1B | 0.73658298 |
| 84 | SGK223 | 0.73429284 |
| 85 | SGK494 | 0.73429284 |
| 86 | KDR | 0.72910870 |
| 87 | SGK2 | 0.72889288 |
| 88 | TSSK6 | 0.72875506 |
| 89 | PRKAA1 | 0.72820981 |
| 90 | PLK1 | 0.70741855 |
| 91 | MTOR | 0.70099231 |
| 92 | RPS6KB2 | 0.69267817 |
| 93 | RPS6KA6 | 0.68949705 |
| 94 | AURKA | 0.66479018 |
| 95 | PRKAA2 | 0.66242047 |
| 96 | CAMKK1 | 0.64977805 |
| 97 | CAMK1 | 0.63234763 |
| 98 | CHUK | 0.63189197 |
| 99 | MAP3K8 | 0.62591984 |
| 100 | KIT | 0.61927770 |
| 101 | STK38 | 0.61444817 |
| 102 | NEK9 | 0.61326405 |
| 103 | TXK | 0.61261600 |
| 104 | FER | 0.60829159 |
| 105 | IKBKE | 0.60128744 |
| 106 | RPS6KA2 | 0.60055833 |
| 107 | MAP2K6 | 0.59498845 |
| 108 | ERBB2 | 0.59148639 |
| 109 | MAP2K4 | 0.59148354 |
| 110 | PTK2 | 0.58940250 |
| 111 | PRKD1 | 0.58470098 |
| 112 | FRK | 0.57999161 |
| 113 | CAMK1D | 0.56697470 |
| 114 | STK39 | 0.54893825 |
| 115 | BMPR1B | 0.54543233 |
| 116 | TYK2 | 0.54494480 |
| 117 | PTK6 | 0.53446403 |
| 118 | GRK6 | 0.53405699 |
| 119 | FGFR2 | 0.53288083 |
| 120 | CDK7 | 0.52500720 |
| 121 | SIK2 | 0.52480396 |
| 122 | WNK1 | 0.52346069 |
| 123 | RPS6KL1 | 0.52299300 |
| 124 | RPS6KC1 | 0.52299300 |
| 125 | AURKB | 0.51947797 |
| 126 | STK3 | 0.50318909 |
| 127 | OXSR1 | 0.50294024 |
| 128 | SGK3 | 0.50089182 |
| 129 | GSK3A | 0.49282886 |
| 130 | PNCK | 0.49123258 |
| 131 | PRKCZ | 0.48855923 |
| 132 | CDK6 | 0.47815643 |
| 133 | ITK | 0.47462212 |
| 134 | IKBKB | 0.47358274 |
| 135 | ADRBK1 | 0.46238176 |
| 136 | MAP2K1 | 0.44000909 |
| 137 | SGK1 | 0.43454127 |
| 138 | RET | 0.43369668 |
| 139 | CSNK1E | 0.42872230 |
| 140 | WNK4 | 0.42200346 |
| 141 | MAP3K5 | 0.41193175 |
| 142 | PRKACG | 0.39305509 |
| 143 | SRPK1 | 0.38969521 |
| 144 | DYRK1B | 0.37071002 |
| 145 | MAPK7 | 0.35460912 |
| 146 | ARAF | 0.34138651 |
| 147 | CSNK2A1 | 0.32967495 |
| 148 | JAK2 | 0.32816346 |
| 149 | MAPKAPK3 | 0.32588680 |
| 150 | NUAK1 | 0.31925934 |
| 151 | AKT2 | 0.31460147 |
| 152 | TIE1 | 0.31174754 |
| 153 | GRK1 | 0.30847991 |
| 154 | CSNK2A2 | 0.29182592 |
| 155 | EPHA3 | 0.28515664 |
| 156 | CHEK2 | 0.27786228 |
| 157 | NME1 | 0.27638733 |
| 158 | MAPK4 | 0.26780824 |
| 159 | PRKCG | 0.26344007 |
| 160 | MAPK12 | 0.25831325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83847083 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96826228 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.93691889 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91421048 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.87024959 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86167943 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66020714 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61942739 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50115742 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44849151 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15454716 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15307717 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13184089 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11368664 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09535538 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08985907 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.07926831 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.04534817 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86730710 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86571178 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.86203532 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.85831818 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84331428 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77084744 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74577560 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73826082 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71284215 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66719957 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62944094 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.61842310 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61210659 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60760340 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52907914 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50706305 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46507301 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45446004 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44111301 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42791870 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39523474 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38450288 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30610763 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30120176 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29752532 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23901551 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22944615 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20860960 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20841079 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20240614 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.19986813 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18250387 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16236306 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12126150 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10268790 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09874352 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04690165 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00475777 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94235443 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92207625 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91926249 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90112358 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.87806566 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85309741 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81206212 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79308114 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.76808306 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69961115 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67828203 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66439651 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65199138 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.64484748 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61648303 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54428015 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51639727 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50373419 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50351035 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49857994 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46581619 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39091794 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37259609 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.36685984 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.36614315 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35844892 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33262133 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.31922599 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28655792 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28476707 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28081974 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25328924 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25232503 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.23600296 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.22777043 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.22510644 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20071099 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.19988725 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.18601590 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18536102 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.17026350 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15390519 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13051800 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12618208 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12216754 |
| 102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11641587 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10107138 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09657317 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.09419526 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.09001295 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.07252219 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.07141178 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.06661249 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06641395 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06166393 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05760850 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04660989 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04375211 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04132451 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04000221 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.00653158 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | -0.1205510 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1190745 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1059954 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0838570 |
| 122 | Mismatch repair_Homo sapiens_hsa03430 | -0.0802034 |
| 123 | Ribosome_Homo sapiens_hsa03010 | -0.0350923 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | -0.0217044 |

